Ad Header



The Pulse of the Pharmaceutical Industry

  • Filter By Category

  • Filter By Author

Shire, Rani agree on hemophilia drug deal

Shire Plc is partnering with California-based Rani Therapeutics to develop a new way to administer a drug to treat hemophilia A.

Read More »

Philippines halts sale of dengue vaccine as Sanofi downplays riskd

The Philippines has ordered French drugmaker Sanofi to stop the sale, distribution and marketing of its Dengvaxia dengue vaccine in the country.

Read More »

Idorsia Scores R&D Deal With Janssen Biotech

J&J’s Janssen Biotech entered into a collaboration deal with Idorsia to jointly develop and market aprocitentan for hypertension and any derivative compounds.

Read More »

Trial results of Zika vaccine Sanofi dropped show promise

A Zika vaccine Sanofi SA dropped during September 2017 under political pressure over pricing produced strong responses in more than 90 percent of those taking part in an early-stage clinical trial, U.S. researchers reported.

Read More »

Sanofi’s Toujeo met main objective in study

Sanofi’s Toujeo met the primary study objective in the first large head-to-head clinical trial, called BRIGHT study, comparing Toujeo with insulin degludec.

Read More »

Montana sues OxyContin maker Purdue over opioid epidemic

Montana sued OxyContin maker Purdue Pharma LP, withdrawing from a multistate investigation by attorneys general into opioid manufacturers’ marketing practices and joining a growing list of states that have broken off to pursue individual lawsuits.

Read More »

Healthcare prices hard to find online

Consumers who search online for prices of common medical procedures may be disappointed by what they find, a U.S. study suggests.

Read More »

Ultragenyx Stock Booms After Burosumab Continues to Impress in Phase III Study

Shares of Ultragenyx sharply climbed after the company announced positive results from its Phase III study of burosumab in adults with X-linked hypophosphatemia (XLH).

Read More »

Philippines orders probe into Sanofi dengue vaccine for 730,000 children

The Philippines ordered a probe on Monday into the immunization of more than 730,000 children with a vaccine for dengue that has been suspended following an announcement by the French drug company Sanofi that it could worsen the disease in some cases.

Read More »

CVS Health to purchase Aetna for $69 billion

CVS Health’s proposed purchase of Aetna will change the way many major U.S. corporations buy health coverage for employees, according to benefit consultants.

Read More »

Ad Right Top


Extensive pharmaceutical business and marketing intelligence. For back issues, please contact

October 2019 Focus: Top 50 Company Profiles & Financials, Outcomes Creativity Index, and more!


Ad Right Bottom